Skip to main content

GABA receptors, progesterone and premenstrual dysphoric disorder

Summary

Premenstrual dysphoric disorder (PMDD) is characterized by depression, anxiety and other affective symptoms which recur in the luteal phase of the menstrual cycle. Evidence from animal models of depression and anxiety indicate the importance of neuroactive steroid hormones and the GABAA receptor in the etiology and potential treatment of mood disorders. These data are reviewed in the light of human clinical studies and specific animal models of PMDD.

This is a preview of subscription content, access via your institution.

Author information

Affiliations

Authors

Additional information

Received April 22, 2002; accepted August 20, 2002 Published online October 30, 2002

Correspondence: Inger Sundström, M.D., Ph.D., Department of Clinical Science, Obstetrics and Gynecology, University Hospital of Umeå, S-901 85 Umeå, Sweden; e-mail: inger.sundstrom@obgyn.umu.se

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sundström Poromaa, I., Smith, S. & Gulinello, M. GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Womens Ment Health 6, 23–41 (2003). https://doi.org/10.1007/s00737-002-0147-1

Download citation

  • Keywords: Progesterone; allopregnanolone; GABA; GABAA-R subunit; animal model; depression; anxiety; premenstrual dysphoric disorder PMDD; human; stress; benzodiazepine; mood; neurosteroid.